Page 54 - Ciences News Today

TORONTO, May 12, 2023 -- Revive Therapeutics Ltd. , a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced... | May 12, 2023

Sales of $4.2 million and Profitability MISSISSAUGA, May 11, 2023 - Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, reports... | May 11, 2023

Item 2.02. Results of Operations and Financial Condition. On May 11, 2023, ATAI Life Sciences N.V. issued a press release announcing its financial results for the quarter ended March 31, 2023... | May 11, 2023

- Significant progress in Comera's ongoing research collaboration with Regeneron, a leading U.S. biotechnology company - - Further development of Comera's pipeline candidate CLS-001 (SQ vedolizumab),

RL-007: First patient dosed in the Phase 2b study of RL-007 in Cognitive Impairment Associated with Schizophrenia.GRX-917: Presented PD data from the completed Phase 1 study, which suggest the potential

EIP Pharma to Present at JMP Securities Life Sciences Conference BOSTON, MA - May 11, 2023 - EIP Pharma Inc., a clinical stage company focused on developing treatments for... | May 11, 2023

Mithilesh Chaudhary, 21, coughs weakly as he struggles to his feet after spending the night outside the state-run All India Institute of Medical Sciences in New Delhi. ... | May 10, 2023

We consider IP Group a compelling healthcare play with 31% of its end-2022 portfolio invested in life sciences companies, or 47% including Oxford Nanopore Technologies (ONT). These investments provide

NORTHAMPTON, MA / ACCESSWIRE / May 10, 2023 / When Jamari Brooks was looking for a new job last fall, he knew he wanted his future employer to have a few key qualities. As he perused pharmaceutical companies'

Proxy adviser Glass Lewis on Wednesday recommended Illumina Inc shareholders support two of Carl Icahns nominees to the U.S. life sciences firms board and vote against re-election of the current... | May 10, 2023